High mRNA expression of MRPL52 in BC was significantly associated with a poorer recurrence-free survival (RFS) [hazard risk (HR) = 1.59, 95% confidence interval (CI): 1.37-1.85, P = 1.8E-09] (Figure 2E). Here, MRPL52 is linked to breast cancer.